Evidence map›Paper›PMID 26849051›Full record

ArticlePloS one2016

Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells.

Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Valentina Santarmaki, Georgios Aindelis, Evgenia Tompoulidou, Eleftheria E Lamprianidou, Georgia Saxami, Petros Ypsilantis, Evangeli S Lampri, Constantinos Simopoulos and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 2 pooled it
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 2 syntheses or guidelines pooled it, 308 citations in OpenAlex.

  1. BioMed research international · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Iranian journal of microbiology · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Microorganisms · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
  19. Review
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Angeliki Tiptiri-KourpetiDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Katerina SpyridopoulouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Valentina SantarmakiDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Georgios AindelisDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Evgenia TompoulidouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Eleftheria E LamprianidouDepartment of Hematology, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Georgia SaxamiDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Petros YpsilantisLaboratory of Experimental Surgery & Surgical Research, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Evangeli S LampriDepartment of Pathology, Medical School, University of Ioannina, Ioannina, Greece.
Constantinos SimopoulosLaboratory of Experimental Surgery & Surgical Research, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Ioannis KotsianidisDepartment of Hematology, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Alex GalanisDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Yiannis KourkoutasDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Dimitra DimitrellouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Katerina ChlichliaDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Democritus University of Thrace · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotic microorganisms such as lactic acid bacteria (LAB) exert a number of strain-specific health-promoting activities attributed to their immunomodulatory, anti-inflammatory and anti-carcinogenic properties. Despite recent attention, our understanding of the biological processes involved in the beneficial effects of LAB strains is still limited. To this end, the present study investigated the growth-inhibitory effects of Lactobacillus casei ATCC 393 against experimental colon cancer. Administration of live Lactobacillus casei (as well as bacterial components thereof) on murine (CT26) and human (HT29) colon carcinoma cell lines raised a significant concentration- and time-dependent anti-proliferative effect, determined by cell viability assays. Specifically, a dramatic decrease in viability of colon cancer cells co-incubated with 10(9) CFU/mL L. casei for 24 hours was detected (78% for HT29 and 52% for CT26 cells). In addition, live L. casei induced apoptotic cell death in both cell lines as revealed by annexin V and propidium iodide staining. The significance of the in vitro anti-proliferative effects was further confirmed in an experimental tumor model. Oral daily administration of 10(9) CFU live L. casei for 13 days significantly inhibited in vivo growth of colon carcinoma cells, resulting in approximately 80% reduction in tumor volume of treated mice. Tumor growth inhibition was accompanied by L. casei-driven up-regulation of the TNF-related apoptosis-inducing ligand TRAIL and down-regulation of Survivin. Taken together, these findings provide evidence for beneficial tumor-inhibitory, anti-proliferative and pro-apoptotic effects driven by this probiotic LAB strain.

Indexed as

ApoptosisProbioticsAnimalsBacterial AdhesionCell Line, TumorCell ProliferationCell SurvivalColonic NeoplasmsCyclin D1Disease Models, AnimalFemaleGene Expression Regulation, NeoplasticHeterograftsHumansHydrogen-Ion ConcentrationInhibitor of Apoptosis ProteinsBIRC5 protein, humanCyclin D1Inhibitor of Apoptosis ProteinsSurvivinTNF-Related Apoptosis-Inducing Ligand

Identifiers

PMID26849051
PMCPMC4744000
OpenAlexW2263582754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.